Sep 22, 2023 8:00am EDT Renowned Spanish Radiologist Lucía Graña-López to Present Data Using IceCure Medical's ProSense at European Society of Breast Imaging Scientific Meeting 2023
Sep 20, 2023 7:00am EDT IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer
Sep 08, 2023 8:00am EDT IceCure Medical to Join Hands-On Cryoablation Session with ProSense and Host Symposium Led by Renowned Doctors at the CIRCE 2023 Annual Congress
Sep 05, 2023 8:00am EDT IceCure Medical's ProSense Cryoablation System Receives Regulatory Approval in Brazil
Aug 28, 2023 8:00am EDT IceCure Medical Takes Next Major Initiative as it Prepares to Accelerate the Commercialization of ProSense in U.S. and Canada: Appoints VP of Sales, North America
Aug 21, 2023 8:00am EDT IceCure Medical Continues to Experience Growing Global Interest in ProSense: Featured at the 16th Thai Breast Symposium
Aug 14, 2023 8:00am EDT IceCure Medical Reports First Half 2023 Financial & Operational Results: Global Adoption of Cryoablation Technology Gaining Momentum
Aug 07, 2023 8:00am EDT IceCure Medical to Report Second Quarter 2023 Financial & Operational Results on August 14, 2023
Jul 24, 2023 8:00am EDT Health Canada Approves IceCure Medical's Minimally Invasive ProSense Cryoablation System
Jul 17, 2023 8:00am EDT IceCure Medical Expands Distribution of ProSense® into Portugal Through Agreement with Medicinália Cormédica: Upfront Systems & Probes Sales
